There is no evidence in the medical literature of adverse events when patients with COVID-19 take nonsteroidal anti-inflammatory drugs (NSAIDs), according to a new scientific brief from the World Health Organization.
However, there are also no studies testing NSAID use in patients with COVID-19, SARS (severe acute respiratory syndrome) or MERS (Middle East respiratory syndrome).
WHO conducted the rapid systematic review on March 20, searching Medline, Embase and the WHO Global Database for any